Skip to main content
Contact Us
Subscribe
E-Edition
80°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Reneo Pharmaceuticals Inc
(NQ:
RPHM
)
1.480
-0.020 (-1.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Reneo Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
5 Analysts Have This to Say About Reneo Pharmaceuticals
December 15, 2023
Via
Benzinga
Nasdaq Turns Lower; US Retail Sales Top Estimates
December 14, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.04% to 37,105.00 while the NASDAQ fell 0.44% to 14,669.25. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 14, 2023
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...
Via
Benzinga
Recap: Reneo Pharmaceuticals Q3 Earnings
November 13, 2023
Via
Benzinga
Reneo Pharmaceuticals: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 14, 2023
Via
Benzinga
Why Is Genetic Disease Focused Reneo Pharmaceuticals Stock Plummeting Today?
December 14, 2023
Reneo Pharmaceuticals Inc (NASDAQ: RPHM) shares are sinking after the company released data from its pivotal STRIDE Phase 2b study of mavodelpar in adult patients with primary mitochondrial myopathies...
Via
Benzinga
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
December 14, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
November 13, 2023
Topline data results from the pivotal STRIDE study are expected in December 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
November 02, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
October 25, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
October 09, 2023
Topline data results from the STRIDE study are expected in December 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
October 06, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
August 29, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
August 28, 2023
Via
Benzinga
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
August 10, 2023
Topline results of the STRIDE study, the pivotal mavodelpar clinical trial in adult patients with primary mitochondrial myopathies (PMM) due to mitochondrial DNA (mtDNA) defects, anticipated in 4Q23
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 3, 2023
July 03, 2023
Via
Benzinga
Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum
June 30, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
June 26, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023
June 15, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
May 31, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
May 31, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Over $65M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
May 11, 2023
Although US stocks closed mixed on Wednesday, there were a few notable insider trades.
Via
Benzinga
Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results
May 11, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 04, 2023
Via
Benzinga
Why Arconic Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
May 04, 2023
Gainers Almaden Minerals Ltd. (NYSE: AAU) gained 72.3% to $0.2111 in pre-market trading after gaining 2% on Wednesday.
Via
Benzinga
PacWest Bancorp, Upwork, Tripadvisor And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
May 04, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Reneo Announces Pricing of Public Offering of Common Stock
May 03, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 03, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.